Status:
COMPLETED
Abbreviated MgSO4 Therapy in Post-partum Preeclampsia
Lead Sponsor:
Case Western Reserve University
Conditions:
Pregnancy
Preeclampsia
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
Magnesium sulfate is used for seizure prophylaxis in pregnancies complicated by preeclampsia. There is debate as to how long to continue this therapy after delivery of the pregnancy. Different schemes...
Detailed Description
The study has been completed at this time. Consenting women with suspected mild preeclampsia (new onset/exacerbated hypertension with proteinuria) were randomly assigned 12 (12-hour) or 24-hours (24-...
Eligibility Criteria
Inclusion
- Women with suspected mild preeclampsia diagnosed antepartum, intrapartum, or post-partum were eligible for inclusion after delivery at term (≥ 34 weeks' gestational age).
Exclusion
- Inability to give informed consent, preterm delivery, severe preeclampsia
Key Trial Info
Start Date :
January 1 2001
Trial Type :
INTERVENTIONAL
End Date :
August 1 2004
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT00344058
Start Date
January 1 2001
End Date
August 1 2004
Last Update
September 10 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
MetroHealth Medical Center, Labor and Delivery
Cleveland, Ohio, United States, 44109